¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Blue Cross Association research series."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • cross fixation
    ±³Â÷ÁÖ½Ã
  • cross foot
    ³»¹ø Á·(Ò®Ûèðë).
  • cross hair
    ½ÊÀÚ¼±
  • cross hatching incision
    ±³Â÷Àý°³
  • cross heredity
    ±³Â÷(¼º)À¯Àü(Îßó©àõë¶îî).
  • cross immunity
    ±³Â÷¸é¿ª(¡­Øóæ¹).
  • cross incision
    ½ÊÀÚÀý°³(½ÊÀÚü°³).
  • cross infection
    ±³Â÷°¨¿°(Îßó©Êïæø).
  • cross inheritance
    ±³Â÷À¯Àü(Îßó©ë¶îî).
  • cross leg flap
    ÇÏÅð±³Â÷ÇÇÆÇ.
  • cross link
    ±³Â÷°áÇÕ, Ⱦ°áÇÕ.
  • cross linking
    ±³Â÷°áÇÕ(Îßó©Ì¿ùê).
  • cross match test
    ±³Â÷½ÃÇè(¡­ãËúÐ).
  • cross matching
    ±³Â÷(ÀûÇÕ)½ÃÇè(¹ý)(¡­îêùêãËúÐÛö).
  • cross neutralization
    ±³Â÷ÁßÈ­ÀÛ¿ë(¡­ñéûúíÂéÄ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
CRI Cardiac Risk Index; catheter-related infection; chronic renal insufficiency; chronic respiratory ins...
CRM Certified Reference Materials; counting rate meter; cross-reacting material; crown-rump measurement
CRP chronic relapsing pancreatitis; corneal-retinal potential; coronary rehabilitation program; C-reacti...
CSE clinical-symptom/self-evaluation [questionnaire]; cone-shaped epiphysis; conventional spin-echo; cro...
DCLHb diaspirin cross-linked hemoglobin
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
TB Trypan Blue
BFP blue fluorescent protein
B-Y blue-yellow
BTB bromothymol blue
ARCI Addiction Research Center Inventory
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
bromphenol blue <chemical> Alpha,alpha-bis(3,5-dibromo-4-hydroxyphenyl)-alpha-hydroxy-o-toluenesulfonic acid, gamma-sultone. A dye that has been used as an industrial dye, a laboratory indicator, and a biological stain.
Pharmacological action: dyes, indicators and reagents.
Chemical name: Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis(2,6-dibromo-, S,S-dioxide
(12 Dec 1998)
bromthymol blue <chemical> A pH sensitive dye that has been used as an indicator in many laboratory reactions.
Pharmacological action: dyes, indicators and reagents.
Chemical name: Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis(2-bromo-3-methyl-6-(1-methylethyl)-, S,S-dioxide
(12 Dec 1998)
carbon monoxide-methylene blue oxidoreductase <enzyme> Molybdenum-containing iron-sulfur flavoprotein from pseudomonas carboxydovorans; forms carbon dioxide
Registry number: EC 1.2.3.-
Synonym: cm-mb oxidoreductase, carbon monoxide oxidase
(26 Jun 1999)
Mallory's aniline blue stain <technique> A method especially suitable for studying connective tissue; sections are stained in acid fuchsin, aniline blue-orange G solution, and phosphotungstic acid; fibrils of collagen are blue, fibroglia, neuroglia, and muscle fibres are red, and fibrils of elastin are pink or yellow.
Synonym: Mallory's aniline blue stain, Mallory's triple stain.
(05 Mar 2000)
Mann's methyl blue-eosin stain <technique> A stain useful for anterior pituitary and viral inclusion bodies; a mixture of the two dyes stains alpha cell granules red, beta cell granules dark blue, chromophobes gray to pink, colloid red, erythrocytes orange-red, and collagen fibres blue; this method is also useful for enterochromaffin, goblet, Paneth, and pancreatic islet cells; Negri bodies appear red while their nuclei and central granules are blue.
(05 Mar 2000)
Victoria blue Any of several blue diphenylnaphthylmethane derivatives; used as a stain in histology.
Origin: Queen Victoria
(05 Mar 2000)
patent blue V A sulfonated triphenylmethane dye reduced and decolorised with zinc and acetic acid to produce a stable solution; used to demonstrate haemoglobin peroxidase.
Synonym: patent blue V.
(05 Mar 2000)
celestine blue B A dye recommended as a substitute for haematoxylin when it is unavailable.
(05 Mar 2000)
cellular blue nevus A large, acquired blue nevus in which melanocytes are often clear and large, alternating with pigmented spindle cells and which may expand deeply into the subcutis; malignant change is very rare.
(05 Mar 2000)
rhodanile blue A dye mixture, considered by some to be a salt of rhodamine B and Nile blue, used to stain keratinised epithelium (red) and fibroblasts (blue), as well as spermatozoa and normal and pathologic acidophilic, basophilic, and certain neutrophilic elements of cells and tissues; used as a substitute for haematoxylin and eosin.
(05 Mar 2000)
Perls' Prussian blue stain <technique> A stain for ferric iron as in haemosiderins, using potassium ferrocyanide in acetic acid or dilute hydrochloric acid followed by a red counterstain such as safranin O or neutral red; various haemosiderins and most mineral irons give a blue-green reaction, while nuclei stain red.
(05 Mar 2000)
methyl blue A sulfonated triphenylrosaniline dye used as a stain for cytoplasm, collagen, and Negri bodies, and as an antiseptic.
(05 Mar 2000)
methylene blue <chemical> Methylthionine chloride; dark green crystals or crystalline powder having a bronze-like luster, readily reduced to colourless leukomethylene blue, which in turn is readily oxidised to methylene blue. Used as a bacteriologic stain and as an indicator, and administered orally or intravenously in the treatment of congenital methemoglobinaemia and cyanide poisoning.
Pharmacological action: anti-infective agents, urinary, antidotes, dyes.
Chemical name: Phenothiazin-5-ium, 3,7-bis(dimethylamino)-, chloride
(12 Dec 1998)
Coomassie blue Stain commonly used non-specifically for proteins on gels. Recently renamed Kenacid Blue.
(18 Nov 1997)
Coomassie brilliant blue R-250 A general protein stain used in electrophoresis because of its unusual sensitivity.
Origin: originally, a proprietary name of Imperial Chemical; Coomassie (Kumasi), Ghana
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • cross-frontier
    °æ°è(¿µ¿ª)¸¦ ³Ñ¾î¼­ ÇàÇÏ¿©Áö´Â
  • cross-garnet
    °í¹«·¡²ÃÀÇ µ¹Â¼±Í
  • cross-grained
    (¸ñÀç°¡)¾ù°áÀÇ;½É¼ú±ÄÀº(perverse)
  • cross-holdings
    (º¹¼öÀÇ È¸»ç¿¡ ÀÇÇÑ ÁÖ½ÄÀÇ)»óÈ£ ¼ÒÀ¯
  • cross-immunity
    ±³Â÷ ¸é¿ª(º´¿ø±Õ°ú À¯¼Ó±ÕÀÇ ¸é¿ª)
  • cross-index
    (Âü°í¼­.»öÀÎ µî¿¡)»óÈ£ ÂüÁ¶ Ç¥½Ã¸¦ ÇÏ´Ù;»óÈ£ ÂüÁ¶
  • cross-legged
    ¹ßÀ» Æ÷°µ(Æ÷°³°í);Ã¥»ó´Ù¸®¸¦ ÇÑ(Çϰí)
  • cross-license
    (´Ù¸¥ ȸ»ç¿Í)»óÈ£ ƯÇã »ç¿ë °è¾àÀ» ¸Î´Ù
  • cross-link
    ±³Â÷ °áÇÕ(¿øÀÚ±º);±³Â÷ °áÇÕ½ÃŰ´Ù(ÇÏ´Ù)
  • cross-match
    (¼öÇ÷ Àü¿¡)±³Â÷(ÀûÇÕ)½ÃÇèÀ» ÇÏ´Ù
  • cross-modal
  • cross-ownership
    (½Å¹®»ç¿Í ¶óµð¿À.ÅÚ·¹ºñÀü ȸ»çÀÇ)°øµ¿¼ÒÀ¯
  • cross-polinate
    ÀÌÈ­¼öºÐ ½ÃŰ´Ù
  • cross-polination
    ÀÌÈ­ ¼öºÐ
  • cross-purpose
    ¹Ý´ë ¸ñÀû;(ÀÇÇâÀÇ) »óÄ¡;µ¿¹®¼­´ä½Ä ¹®´ä³îÀÌ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
ÅëÇÕ°Ë»ö ¿Ï·á